Mitsubishi UFJ Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.44M | Buy |
49,214
+3,968
| +9% | +$277K | ﹤0.01% | 692 |
|
|
2025
Q1 | $3.33M | Buy |
45,246
+4,905
| +12% | +$361K | ﹤0.01% | 680 |
|
|
2024
Q4 | $2.67M | Buy |
40,341
+923
| +2% | +$61.1K | ﹤0.01% | 715 |
|
|
2024
Q3 | $3.07M | Buy |
39,418
+2,131
| +6% | +$166K | ﹤0.01% | 696 |
|
|
2024
Q2 | $2.91M | Buy |
37,287
+2,629
| +8% | +$205K | ﹤0.01% | 694 |
|
|
2024
Q1 | $2.35M | Buy |
34,658
+914
| +3% | +$61.9K | ﹤0.01% | 709 |
|
|
2023
Q4 | $2.31M | Buy |
33,744
+1,440
| +4% | +$98.4K | ﹤0.01% | 710 |
|
|
2023
Q3 | $2.19M | Buy |
32,304
+7,439
| +30% | +$504K | ﹤0.01% | 717 |
|
|
2023
Q2 | $1.78M | Sell |
24,865
-3,868
| -13% | -$277K | ﹤0.01% | 753 |
|
|
2023
Q1 | $1.99M | Sell |
28,733
-780
| -3% | -$54.1K | ﹤0.01% | 730 |
|
|
2022
Q4 | $2.05M | Buy |
29,513
+2,895
| +11% | +$201K | 0.01% | 713 |
|
|
2022
Q3 | $1.46M | Buy |
26,618
+1,782
| +7% | +$97.7K | ﹤0.01% | 740 |
|
|
2022
Q2 | $1.64M | Buy |
24,836
+2,513
| +11% | +$166K | 0.01% | 739 |
|
|
2022
Q1 | $1.48M | Buy |
+22,323
| New | +$1.48M | 0.01% | 784 |
|